source
- FDA proposes new classification that formally recognizes NAC as a dietary ingredient, ending its legal gray areaThe FDA announced a proposed rule that would create a new regulatory category for N-acetyl-L-cysteine (NAC), a product long sold as a dietary supplement. Under the proposal, NAC would be classifie…
- Aclaris Therapeutics’ bosakitug fails Phase 2 eczema trial, TSLP program droppedAclaris Therapeutics announced that its experimental antibody bosakitug (ATI-045) did not meet the primary endpoint in a Phase 2 study for moderate-to-severe atopic dermatitis. The double‑blind Ad…